Safety and efficacy of eculizumab in the prevention of antibody-mediated rejection in living-donor kidney transplant recipients requiring desensitization therapy: A randomized trial

WH Marks, N Mamode, RA Montgomery, MD Stegall, LE Ratner, LD Cornell, Ajda Rowshani, RB Colvin, B Dain, JA Boice, D Glotz

Research output: Contribution to journalArticleAcademicpeer-review

65 Citations (Scopus)
4 Downloads (Pure)
Original languageUndefined/Unknown
Pages (from-to)2876-2888
Number of pages13
JournalAmerican Journal of Transplantation
Issue number10
Publication statusPublished - 2019

Cite this